Denver-based Shaman Mushroom Spores is offering high-quality psilocybe cubensis mushroom spore syringes exclusively available for research purposes.
See also: Link Between Cancer And Psilocybin: Research On This Palliative Promise
The business was founded to obtain psilocybin spores for microscopy research purposes, each syringe containing hundreds of thousands of mushroom spores (each black dot visible with the naked eye is actually a cluster of hundreds of spores.)
See also: Psychedelics In Colorado: Gov Ratifies Bill, Report Shows No Increase In Public Health Harms
“Our mushroom spore syringes are lab-tested and quality-controlled, assuring researchers and customers the highest possible purity standards,” said a company spokesperson. “With the study of psilocybin mushrooms now in its renaissance, we pride ourselves on our meticulous microscopic research, offering quality that exceeds industry standards.”
See also: Magic Mushroom Microdosing: Why The Trend Is Catching On And What The Practice Is All About
The past years show an increasing amount of research on classical psychedelics, including psilocybin mushrooms, with sound evidence on this substance’s beneficial effects over a wide array of mental health conditions including addictions and depression, with potential long-term advantages.
Photo: Benzinga edit with photo by cottonbro and Chokniti Khongchum on Pexels.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Click on the image for more info.
Cannabis rescheduling seems to be right around the corner
Want to understand what this means for the future of the industry?
Hear directly for top executives, investors and policymakers at the Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9.
Get your tickets now before prices surge by following this link.